title: Secretin available under FDA treatment protocol.
authors.forename: Karim Anton
authors.initials: KA
authors.lastname: Calis
authors.forename: Charles E
authors.initials: CE
authors.lastname: Daniels
mesh_terms: D017277:Drug Approval; D012633:Secretin / Q000627:therapeutic use*; D014481:United States; D014486:United States Food and Drug Administration
chemical_list: D012633:Secretin